The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population‐based modelling study
Authors' conclusion
The substantial population health and economic burden of inadequate risk factor control for individuals with diabetes in Hong Kong can potentially be mitigated through enhanced adherence, highlighting the need for effective and intensive interventions.
Study context
- Population
- All individuals with T2D in Hong Kong in 2021, electronic healthcare records of the Hong Kong Hospital Authority
- Participants
- 526,672 individuals
- Exposure
- Immediate risk factor control vs baseline
- Outcome
- Combined control (HbA1c, blood pressure and LDL-C)
- Follow-up
- 10 years
Methodological detailspatient-level diabetes outcomes model (CHIME), healthcare provider perspective, 10-year horizon
- Patient-level diabetes outcomes model (CHIME)
- Healthcare provider perspective
- 10-year horizon
Main finding
As reported in the abstract
Population-level increase in quality-adjusted life-years (QALYs) with combined control
17 605
Healthcare cost savings with combined control
US$ 106.7 million
Observational data: associations, not effects.
Further findings
Baseline risk factor control
- Failed to achieve optimal combined risk factor control
- 84.9%
Glycaemic control alone · 10 years
- Highest cost savings
- US$ 29.0 million
- Greatest QALY increases
Original publication
The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population‐based modelling study. Diabetes Obes Metab. Published 10 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →